Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo
- PMID: 11886510
- DOI: 10.1046/j.0022-202x.2001.01605.x
Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo
Abstract
Vitiligo is a cutaneous pigmentary disorder characterized by the loss of melanocytes. An autoimmune mechanism is strongly suspected to be involved in this affection given that it is frequently associated with autoimmune hormonal disorders, and because antibodies directed against melanocytic antigens are found in the serum of patients with vitiligo. We examined the role of cellular immunity in melanoma-associated vitiligo by expanding infiltrating lymphocytes from fresh biopsy specimens of vitiligo patches in melanoma patients. The vitiligo-infiltrating lymphocytes were almost exclusively T lymphocytes, and most were CD8(+). Following in vitro expansion, vitiligo-infiltrating lymphocytes remained predominantly CD8(+) and expressed the cutaneous homing receptor CLA. Furthermore, vitiligo-infiltrating lymphocytes had a clonal or oligoclonal T cell receptor profile, possibly reflecting specific antigenic stimulation. Finally, vitiligo- infiltrating lymphocytes specifically recognized differentiation antigens shared by normal melanocytes and melanoma cells. This direct demonstration of CD8(+) T cell involvement in vitiligo suggests that, in melanoma patients, vitiligo may be a visible effect of a spontaneous antitumoral immune response.
Similar articles
-
Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?Pigment Cell Res. 2005 Aug;18(4):234-42. doi: 10.1111/j.1600-0749.2005.00244.x. Pigment Cell Res. 2005. PMID: 16029417 Review.
-
Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo.J Exp Med. 2000 Dec 4;192(11):1637-44. doi: 10.1084/jem.192.11.1637. J Exp Med. 2000. PMID: 11104805 Free PMC article.
-
Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.J Invest Dermatol. 2001 Aug;117(2):326-32. doi: 10.1046/j.1523-1747.2001.01408.x. J Invest Dermatol. 2001. PMID: 11511311
-
Melanocyte-specific immune response in a patient with multiple regressing nevi and a history of melanoma.Anticancer Res. 2011 Nov;31(11):3697-703. Anticancer Res. 2011. PMID: 22110189
-
Therapeutic implications of autoimmune vitiligo T cells.Autoimmun Rev. 2006 Aug;5(7):486-92. doi: 10.1016/j.autrev.2006.03.012. Epub 2006 May 6. Autoimmun Rev. 2006. PMID: 16920575 Free PMC article. Review.
Cited by
-
Selection Signatures in Italian Goat Populations Sharing the "facciuto" Phenotype.Genes (Basel). 2025 Mar 28;16(4):390. doi: 10.3390/genes16040390. Genes (Basel). 2025. PMID: 40282350 Free PMC article.
-
Vitiligo-like rash in a patient with lung cancer caused by sintilimab: A case report.World J Clin Cases. 2025 May 16;13(14):101981. doi: 10.12998/wjcc.v13.i14.101981. World J Clin Cases. 2025. PMID: 40385299 Free PMC article.
-
Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity.Nat Immunol. 2021 Jul;22(7):809-819. doi: 10.1038/s41590-021-00949-7. Epub 2021 Jun 17. Nat Immunol. 2021. PMID: 34140679 Free PMC article. Review.
-
Transfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategy.J Autoimmune Dis. 2005 Aug 31;2:7. doi: 10.1186/1740-2557-2-7. J Autoimmune Dis. 2005. PMID: 16135249 Free PMC article.
-
Immune-related cutaneous adverse events due to checkpoint inhibitors.Ann Allergy Asthma Immunol. 2021 Jun;126(6):613-622. doi: 10.1016/j.anai.2021.02.009. Epub 2021 Feb 17. Ann Allergy Asthma Immunol. 2021. PMID: 33609771 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials